Cibus, Inc.
Cibus, Inc. (CBUS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cbus · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cibus, Inc. (CBUS) measures how much investors pay for each dollar of the company's trailing earnings. CBUS's current PE ratio of N/A is calculated by dividing its stock price of $1.25 by its TTM earnings per share of -$0.16.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cibus, Inc.You CBUS | $57M | N/A | — | -$0.16 |
 Acrivon Therapeutics, Inc. Common Stock ACRV | $46M | N/A | — | -$2.02 |
 Biomea Fusion, Inc. BMEA | $71M | N/A | — | -$1.18 |
 CAMP4 Therapeutics Corporation CAMP | $90M | N/A | — | -$2.65 |
 Immunic, Inc. IMUX | $127M | N/A | — | -$6.24 |
 MediciNova, Inc. MNOV | $64M | N/A | — | -$0.24 |
 PMV Pharmaceuticals, Inc. PMVP | $59M | N/A | — | -$1.48 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.28 | — | |
2024-12-31 FY2024 | — | $-10.83 | — | |
2023-12-31 FY2023 | — | $-25.95 | — | |
2022-12-31 FY2022 | — | $-0.03 | — | |
2021-12-31 FY2021 | — | $-0.05 | — | |
2020-12-31 FY2020 | — | $-0.07 | — | |
2019-12-31 FY2019 | — | $-0.06 | — | |
2018-12-31 FY2018 | — | $-0.05 | — | |
2017-12-31 FY2017 | — | $-0.06 | — | |
2016-12-31 FY2016 | — | $-0.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cibus, Inc. (CBUS) measures how much investors pay for each dollar of the company's trailing earnings. CBUS's current PE ratio of N/A is calculated by dividing its stock price of $1.25 by its TTM earnings per share of -$0.16.
Frequently asked questions
CBUS pe ratio · 6 questionsCBUS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.25 and TTM EPS of -$0.16. Data sourced from Financial Modeling Prep via CBUS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cibus, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09